quitline smoking intervention : “talk” randomized trial

29
Quitline Smoking Intervention: “TALK” Randomized Trial Jonathan B. Bricker, PhD Fred Hutchinson Cancer Research Center University of Washington

Upload: yaphet

Post on 06-Jan-2016

40 views

Category:

Documents


2 download

DESCRIPTION

Quitline Smoking Intervention : “TALK” Randomized Trial. Jonathan B. Bricker, PhD Fred Hutchinson Cancer Research Center University of Washington. Scientific Collaborators & Project Partners. Jan Blalock, PhD, Psychologist, Univ of Texas/MD Anderson - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Quitline  Smoking Intervention : “TALK” Randomized Trial

Quitline Smoking Intervention: “TALK” Randomized Trial

Jonathan B. Bricker, PhDFred Hutchinson Cancer Research Center

University of Washington

Page 2: Quitline  Smoking Intervention : “TALK” Randomized Trial

Scientific Collaborators & Project Partners

Jan Blalock, PhD, Psychologist, Univ of Texas/MD Anderson

Terry Bush, PhD, Psychologist, Alere, Seattle

Jaimee Heffner, PhD, Psychologist, FHCRC

Julie Kientz, PhD, Computer Scientist, UW

Jennifer McClure, PhD, Psychologist, Group Health

Roger Vilardaga, PhD, Psychologist, FHCRC/UW

2 Morrow Inc., Mobile Health, Seattle

Blink UX, Web Design, Seattle

Collaborative Data Services, Data ops, FHCRC

Harvard University Health Communications, Boston

Moby, Web Programming, Seattle

Nutrition Assessment Shared Resource, Data ops, FHCRC

Page 3: Quitline  Smoking Intervention : “TALK” Randomized Trial

Funding Sources National Cancer Institute

R01-CA-166646 (PI: Bricker)

R01-CA-151251 (PI: Bricker)

R01-CA-120153 (PI: Blalock)

National Institute on Drug Abuse

R21-DA-030646 (PI: Bricker)

K23-DA-0265517 (PI: Heffner)

K99-DA-0037276 (PI: Vilardaga)

Hartwell Innovation Fund (PI: Bricker)

Fred Hutchinson Cancer Research Center (PI: Bricker)

Page 4: Quitline  Smoking Intervention : “TALK” Randomized Trial

Today’s Tobacco Consequences

The leading cause of preventable death, killing 480K US (Surgeon General, 2014) & 6 million worldwide (WHO, 2013).

Causes lung and multiple cancers, hypertension, CHD, and stroke (Surgeon General, 2014).

$289 Billion in US medical and lost productivity costs (Surgeon General, 2014).

Page 5: Quitline  Smoking Intervention : “TALK” Randomized Trial

Reach & Efficacy of Smoking Intervention Modalities

Reach(# of million using modality annually)

1m 2m 3m 4m

Efficacy(% Quit at

12 months)

30%

20%

10%

Individual

Web

Telephone

Group

Page 6: Quitline  Smoking Intervention : “TALK” Randomized Trial

Acceptance & Commitment Therapy (ACT) is a Potential

Solution to the Problem of Low Quit Rates

Page 7: Quitline  Smoking Intervention : “TALK” Randomized Trial

Acceptance of our

“baggage”

Committed Action in valued

direction

Page 8: Quitline  Smoking Intervention : “TALK” Randomized Trial

Pathways to Acceptance

Mindfulness: Present-moment focused attention in the face of challenging circumstances

Defusion: Stepping back and watching the process of thinking

Self-as-Context: The “part” of us that is aware of what we think, feel, and sense

Page 9: Quitline  Smoking Intervention : “TALK” Randomized Trial

Pathways to Commitment

Values: What deeply matters; want you want your life to be about

Action: Doing what it takes, guided by what deeply matters

Page 10: Quitline  Smoking Intervention : “TALK” Randomized Trial

Acceptance & Commitment Lead to Life-Embracing Behavior

Change

Mindfulness

Defusion

Self As Context

Acceptance

Values

Commitment

Action

Life-Embracing Behavior Change

Page 11: Quitline  Smoking Intervention : “TALK” Randomized Trial

Domain ACT Standard SC Treatment

Theoretical basis Relational frame theory

Information processing theories

Approach for handling smoking cues

Acceptance Avoidance

Approach for increasing motivation

Values Reasons to change

Methods for skill training

Metaphorical, experiential

Literal and logical, explanatory

ACT vs. Standard ACT vs. Standard TreatmentTreatment

Page 12: Quitline  Smoking Intervention : “TALK” Randomized Trial

ACT Research Program: “The Wheel”

Page 13: Quitline  Smoking Intervention : “TALK” Randomized Trial

Telephone-Delivered ACT for Smoking Cessation

Page 14: Quitline  Smoking Intervention : “TALK” Randomized Trial

Quitlines: Address Barriers to Reach

Accessible: In US, 95% have a telephone. (Pew Internet & American Life Project, 2009)

Available: All 50 States have a quitline as do most of Europe and Latin America

Cost-effective: Covered by insurance, Medicaid, or the state. Costs less than group and with only 25% lower fraction of effectiveness.

Relatively brief: about 90 minutes total (3 to 9 sessions)

Many demographics make use: Men, minorities, poor

Page 15: Quitline  Smoking Intervention : “TALK” Randomized Trial

Phase II Trial of Telephone-Delivered ACT vs. CBT for

Smoking Cessation (R21DA030646; PI: Bricker)

Primary Aim 1: Compare ACT with CBT on implementation outcomes

Primary Aim 2: Demonstrate that ACT, as compared to CBT, has trend toward cessation. Primary outcome: 30 pp at 6 month post tx

Primary Aim 3: Determine mediation by acceptance of smoking cues and commitment to quitting

Page 16: Quitline  Smoking Intervention : “TALK” Randomized Trial

TALK Consort Diagra

m

Screened (n=237)

Excluded (n= 87)Declined Eligibility Survey (n=46)Ineligible (n=36)Did not take Baseline Survey (n=5)

Analysed for 3 months (n=59)Analysed for 6 months (n=59)

Lost to follow-up 3-months (n= 19)Lost to follow-up 6-months (n=16)

Allocated to intervention (n=59)Received 5 calls (n=28)Received 4 calls (n=4)Received 3 calls (n=5)Received 2 calls (n=7)Received 1 calls (n=7)Received 0 calls (n= 8)

Lost to follow-up 3-months (n= 22)Lost to follow-up 6-months (n= 24)

Allocated to CBT (n=62)Received 5 calls (n=3)Received 4 calls (n=6)Received 3 calls (n=21)Received 2 calls (n=10)Received 1 calls (n=16)Received 0 calls (n=6)

Analysed for 3 months (n=62)Analysed for 6 months (n=62)

Allocation

Analysis

Follow-Up

Randomized (n= 121)

Enrollment

Eligible (n=150)

Excluded (n= 29)Did not confirm by phone (n=29)

Page 17: Quitline  Smoking Intervention : “TALK” Randomized Trial

Aim 1: Baseline Demographics & Retention

Demographic

Overall(N= 121)

CBT(n=62)

ACT(n=59)

Baselinep=value

Outcomep=value

Age, mean 39.1 38.6 39.6 0.55 0.89

Female 69% 73% 66% 0.40 0.09

Caucasian 73% 69% 76% 0.39 0.16

Married 28% 29% 27% 0.82 0.51

Working 37% 31% 44% 0.13 0.80

HS or less 55% 53% 56% 0.77 0.20

Page 18: Quitline  Smoking Intervention : “TALK” Randomized Trial

Aim 1: Baseline Smoking & Social Env at Baseline & Retention

Demographic

Overall(N = 121)

CBT(n=62)

ACT(n=59

)Baselinep=value

Outcomep=value

Smoking Behavior

At least-a-pack/day

36% 29% 42% 0.13 0.63

Smoked x>10 years

75% 76% 75% 0.88 0.86

Health Behaviors

Depression score, mean

6.3 6.4 6.2 0.78 0.12

Heavy drinker 11% 7% 16% 0.11 1Weight, mean lbs.

187.5 190.7 184.3 0.46 0.68

Env. Smoking

Close friends smoke, mean

3.1 3.0 3.1 0.78 0.45

Partner smokes

37% 34% 41% 0.44 0.39

Page 19: Quitline  Smoking Intervention : “TALK” Randomized Trial

Calls Attempted & Completed

CBTMean (SD)

ACTMean (SD)

p-value

Total Call Attempts 17.9 (6.7) 12.2 (5.2) 0.0001

Number of Calls Completed 1.69 (1.3) 3.25 (1.94) 0.001

Completed All 5 Calls 3 (4.8%) 28 (47.5%) 0.001

Page 20: Quitline  Smoking Intervention : “TALK” Randomized Trial

Aim 1: Treatment Competence

CBT ACTp-value

Agreement 90.9% 98.7% 0.10

Mean (SD) 4.58 (0.64)4.92

(0.34)0.10

Page 21: Quitline  Smoking Intervention : “TALK” Randomized Trial

Aim 2: NRT Usage

CBT ACT p-value

NRT Usage 73% 67% 0.59

Page 22: Quitline  Smoking Intervention : “TALK” Randomized Trial

Aim 2: Tx Satisfaction

CBT ACT p-value

Satisfied overall 85% 97% 0.10

Recommend to friend 83% 97% 0.06

Program’s skills useful to quit 87% 100% 0.03

Page 23: Quitline  Smoking Intervention : “TALK” Randomized Trial

Aim 3: 6M Quit (30D PP)

CBT ACTOR

(95% CI)

22% 31%1.5

(0.7, 3.4)

Page 24: Quitline  Smoking Intervention : “TALK” Randomized Trial

6-Month Quit (30D PP) in Key Baseline Subgroups

Baseline Subgroup CBT ACTOR

(95% CI)

Pack-A-Day or More 17% 36%2.8 (0.6, 12.4)

Screened Depressed 13% 33%1.2

(1.0-1.6)

Avoidant of Cravings 10% 37%5.3 (1.3, 22.0)

Page 25: Quitline  Smoking Intervention : “TALK” Randomized Trial

Aim 3: Impact on Avoidance

CBTmean (SD)

ACTmean (SD) p-value

Avoidance of Cravings 2.13 (0.42) 2.41 (0.67) 0.04

Page 26: Quitline  Smoking Intervention : “TALK” Randomized Trial

Aim 3: ACT3M Avoidance6M Quit

Beta (SE) p-Value

ACT (vs. CBT)3M Avoidance

0.29 (0.14) 0.04

3M Avoidance6M Quit Rate

2.69 (0.71) 0.001

Page 27: Quitline  Smoking Intervention : “TALK” Randomized Trial

Conclusions: Telephone ACT is…

Feasible to deliver

Acceptable to quitline callers

Showing promising quit rates compared to CBT

Operating according to its theoretical model

Ready for a fully-powered RCT

Page 28: Quitline  Smoking Intervention : “TALK” Randomized Trial

Next Grant…

Results stimulated an NIDA research grant application for $3 million

Fully-powered RCT of 1100 participants with one year follow-up

June 2014: Perfect Score in Study Section!

Page 29: Quitline  Smoking Intervention : “TALK” Randomized Trial

Many Thanks!

Contact: Dr. Jonathan Bricker

Email: [email protected]